Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1981 Mar-Apr;22(2):141-4.

Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery

P T Harajola, H Meurala, M H Frick
  • PMID: 7014570
Clinical Trial

Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery

P T Harajola et al. J Cardiovasc Surg (Torino). 1981 Mar-Apr.

Abstract

In this prospective study 364 patients were subjected to different types of arterial reconstructive surgery. The patients were randomly divided into four groups according to the type of antithrombotic medication given. During the hospitalization period there were no reocclusions in the dipyridamole/ASA group of 93 patients compared with 12 reocclusions in the control group of 86 patients. The difference was statistically highly significant. The difference between the control group and the given dipyridamole or ASA was not statistically significant. Dipyridamole and ASA were tolerated well by the patients in this clinical trial. This was the first clinical investigation to prove the effectiveness of dipyridamole and ASA medication in the prevention of reocclusions in arterial reconstructive bypass surgery.

PubMed Disclaimer

Publication types